drugset / Trial / NCT00332761

Caduet in an Untreated Subject Population

NCT00332761

Phase 4 Completed 220 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if Caduet will lower blood pressure to \<140/90 mmHg and lower LDL Cholesterol to \<100 mg/dL in subjects with hypertension and dyslipidemia who are not currently being treated for these medical conditions.

Timeline

Start
2006-06
Primary completion
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Caduet Unknown